TNFSF15 and neoplasm: This process also occurs in vivo, because treatment of the mouse LLC tumor model with TNFSF15 enhanced the CD11b+ cell population percentage in the bone marrow, and significantly increased the percentage of tumor-infiltrated pericytes and their association with vascular endothelial cells.